25 XP   0   0   10

Santhera Pharmaceuticals Holding AG
Buy, Hold or Sell?

Let's analyse Santhera together

PenkeI guess you are interested in Santhera Pharmaceuticals Holding AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Santhera Pharmaceuticals Holding AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Santhera Pharmaceuticals Holding AG

I send you an email if I find something interesting about Santhera Pharmaceuticals Holding AG.

Quick analysis of Santhera (30 sec.)










What can you expect buying and holding a share of Santhera? (30 sec.)

How much money do you get?

How much money do you get?
£0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
£-6.79
Expected worth in 1 year
£-34.77
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
£-27.98
Return On Investment
-286.7%

For what price can you sell your share?

Current Price per Share
£9.76
Expected price per share
£14.02 - £11.34
How sure are you?
50%

1. Valuation of Santhera (5 min.)




Live pricePrice per Share (EOD)

£9.76

Intrinsic Value Per Share

£-112.97 - £-134.68

Total Value Per Share

£-119.76 - £-141.47

2. Growth of Santhera (5 min.)




Is Santhera growing?

Current yearPrevious yearGrowGrow %
How rich?-$54.3m$1.6m-$55.9m-103.0%

How much money is Santhera making?

Current yearPrevious yearGrowGrow %
Making money-$88.3m-$69m-$19.3m-21.9%
Net Profit Margin-951.1%3,481.3%--

How much money comes from the company's main activities?

3. Financial Health of Santhera (5 min.)




What can you expect buying and holding a share of Santhera? (5 min.)

Welcome investor! Santhera's management wants to use your money to grow the business. In return you get a share of Santhera.

What can you expect buying and holding a share of Santhera?

First you should know what it really means to hold a share of Santhera. And how you can make/lose money.

Speculation

The Price per Share of Santhera is £9.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Santhera.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Santhera, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is £-6.79. Based on the TTM, the Book Value Change Per Share is £-6.99 per quarter. Based on the YOY, the Book Value Change Per Share is £1.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is £0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Santhera.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 £% of Price per Share£% of Price per Share£% of Price per Share£% of Price per Share£% of Price per Share
Usd Eps-13.73-140.7%-13.73-140.7%-10.73-109.9%-10.34-105.9%-10.27-105.2%
Usd Book Value Change Per Share-8.70-89.1%-8.70-89.1%1.4815.2%-2.94-30.1%-1.41-14.4%
Usd Dividend Per Share0.000.0%0.000.0%0.141.5%0.232.4%0.192.0%
Usd Total Gains Per Share-8.70-89.1%-8.70-89.1%1.6316.7%-2.71-27.7%-1.22-12.5%
Usd Price Per Share1.74-1.74-0.00-3.89-3.24-
Price to Earnings Ratio-0.13--0.13-0.00--0.86--0.71-
Price-to-Total Gains Ratio-0.20--0.20--10.35--10.35-
Price to Book Ratio-0.21--0.21-0.00-0.10-0.08-
Price-to-Total Gains Ratio-0.20--0.20--10.35--10.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.137536
Number of shares82
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.23
Usd Book Value Change Per Share-8.70-2.94
Usd Total Gains Per Share-8.70-2.71
Gains per Quarter (82 shares)-713.28-221.85
Gains per Year (82 shares)-2,853.11-887.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2853-286375-963-897
20-5706-5716151-1925-1784
30-8559-8569226-2888-2671
40-11412-11422301-3851-3558
50-14266-14275376-4813-4445
60-17119-17128452-5776-5332
70-19972-19981527-6739-6219
80-22825-22834602-7701-7106
90-25678-25687678-8664-7993
100-28531-28540753-9627-8880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.04.00.033.3%2.04.00.033.3%
Dividend per Share0.00.01.00.0%2.00.01.066.7%3.00.02.060.0%3.00.03.050.0%3.00.03.050.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.04.00.033.3%2.04.00.033.3%

Fundamentals of Santhera

About Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.

Fundamental data was last updated by Penke on 2024-04-17 23:13:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Santhera Pharmaceuticals Holding AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Santhera earns for each £1 of revenue.

  • Above 10% is considered healthy but always compare Santhera to the  industry mean.
  • A Net Profit Margin of -951.1% means that £-9.51 for each £1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is -951.1%. The company is making a huge loss. -2
  • The TTM is -951.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-951.1%TTM-951.1%0.0%
TTM-951.1%YOY3,481.3%-4,432.4%
TTM-951.1%5Y376.6%-1,327.7%
5Y376.6%10Y276.4%+100.2%
1.1.2. Return on Assets

Shows how efficient Santhera is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Santhera to the  industry mean.
  • -111.5% Return on Assets means that Santhera generated £-1.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is -111.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -111.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-111.5%TTM-111.5%0.0%
TTM-111.5%YOY-60.9%-50.6%
TTM-111.5%5Y-62.9%-48.7%
5Y-62.9%10Y-60.2%-2.7%
1.1.3. Return on Equity

Shows how efficient Santhera is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Santhera to the  industry mean.
  • 0.0% Return on Equity means Santhera generated £0.00 for each £1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-4,181.2%+4,181.2%
TTM-5Y-893.0%+893.0%
5Y-893.0%10Y-770.8%-122.2%

1.2. Operating Efficiency of Santhera Pharmaceuticals Holding AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Santhera is operating .

  • Measures how much profit Santhera makes for each £1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Santhera to the  industry mean.
  • An Operating Margin of -613.8% means the company generated £-6.14  for each £1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is -613.8%. The company is operating very inefficient. -2
  • The TTM is -613.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-613.8%TTM-613.8%0.0%
TTM-613.8%YOY3,582.1%-4,195.8%
TTM-613.8%5Y488.0%-1,101.8%
5Y488.0%10Y370.0%+118.0%
1.2.2. Operating Ratio

Measures how efficient Santhera is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 7.14 means that the operating costs are £7.14 for each £1 in net sales.

Let's take a look of the Operating Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is 7.138. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.138. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ7.138TTM7.1380.000
TTM7.138YOY-34.821+41.958
TTM7.1385Y-4.376+11.513
5Y-4.37610Y-3.616-0.759

1.3. Liquidity of Santhera Pharmaceuticals Holding AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Santhera is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 0.06 means the company has £0.06 in assets for each £1 in short-term debts.

Let's take a look of the Current Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is 0.062. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.062. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.0620.000
TTM0.062YOY0.752-0.690
TTM0.0625Y1.133-1.071
5Y1.13310Y1.921-0.788
1.3.2. Quick Ratio

Measures if Santhera is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Santhera to the  industry mean.
  • A Quick Ratio of 0.05 means the company can pay off £0.05 for each £1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is 0.049. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.049. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.049TTM0.0490.000
TTM0.049YOY0.706-0.657
TTM0.0495Y0.919-0.869
5Y0.91910Y1.730-0.811

1.4. Solvency of Santhera Pharmaceuticals Holding AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Santhera assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Santhera to industry mean.
  • A Debt to Asset Ratio of 1.69 means that Santhera assets are financed with 168.6% credit (debt) and the remaining percentage (100% - 168.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is 1.686. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.686. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.686TTM1.6860.000
TTM1.686YOY0.985+0.700
TTM1.6865Y1.061+0.624
5Y1.06110Y1.002+0.059
1.4.2. Debt to Equity Ratio

Measures if Santhera is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Santhera to the  industry mean.
  • A Debt to Equity ratio of 0.0% means that company has £0.00 debt for each £1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY67.612-67.612
TTM-5Y14.998-14.998
5Y14.99810Y12.899+2.099

2. Market Valuation of Santhera Pharmaceuticals Holding AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every £1 in earnings Santhera generates.

  • Above 15 is considered overpriced but always compare Santhera to the  industry mean.
  • A PE ratio of -0.13 means the investor is paying £-0.13 for every £1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The EOD is -0.884. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.127. Based on the earnings, the company is expensive. -2
  • The TTM is -0.127. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.884MRQ-0.127-0.757
MRQ-0.127TTM-0.1270.000
TTM-0.127YOY--0.127
TTM-0.1275Y-0.858+0.731
5Y-0.85810Y-0.715-0.143
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The EOD is -1.858. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.267. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.267. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.858MRQ-0.267-1.591
MRQ-0.267TTM-0.2670.000
TTM-0.267YOY--0.267
TTM-0.2675Y6.121-6.388
5Y6.12110Y5.101+1.020
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Santhera is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of -0.21 means the investor is paying £-0.21 for each £1 in book value.

Let's take a look of the Price to Book Ratio trends of Santhera Pharmaceuticals Holding AG:

  • The EOD is -1.438. Based on the equity, the company is expensive. -2
  • The MRQ is -0.207. Based on the equity, the company is expensive. -2
  • The TTM is -0.207. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.438MRQ-0.207-1.231
MRQ-0.207TTM-0.2070.000
TTM-0.207YOY--0.207
TTM-0.2075Y0.099-0.306
5Y0.09910Y0.083+0.017
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Santhera Pharmaceuticals Holding AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---6.995-6.9950%1.194-686%-2.360-66%-1.131-84%
Book Value Per Share---6.788-6.7880%0.206-3390%0.011-60108%0.845-904%
Current Ratio--0.0620.0620%0.752-92%1.133-95%1.921-97%
Debt To Asset Ratio--1.6861.6860%0.985+71%1.061+59%1.002+68%
Debt To Equity Ratio----0%67.612-100%14.998-100%12.899-100%
Dividend Per Share----0%0.115-100%0.185-100%0.154-100%
Eps---11.044-11.0440%-8.628-22%-8.311-25%-8.260-25%
Free Cash Flow Per Share---5.252-5.2520%-5.807+11%-4.364-17%-4.364-17%
Free Cash Flow To Equity Per Share---3.078-3.0780%1.344-329%-0.973-68%-0.973-68%
Gross Profit Margin--1.1531.1530%1.168-1%1.310-12%1.258-8%
Intrinsic Value_10Y_max---134.677--------
Intrinsic Value_10Y_min---112.970--------
Intrinsic Value_1Y_max---7.587--------
Intrinsic Value_1Y_min---7.373--------
Intrinsic Value_3Y_max---27.300--------
Intrinsic Value_3Y_min---25.702--------
Intrinsic Value_5Y_max---52.441--------
Intrinsic Value_5Y_min---47.783--------
Market Cap62810772.800+86%9022613.0609022613.0600%-+100%20139347.582-55%16782789.652-46%
Net Profit Margin---9.511-9.5110%34.813-127%3.766-353%2.764-444%
Operating Margin---6.138-6.1380%35.821-117%4.880-226%3.700-266%
Operating Ratio--7.1387.1380%-34.821+588%-4.376+161%-3.616+151%
Pb Ratio-1.438-596%-0.207-0.2070%--100%0.099-308%0.083-350%
Pe Ratio-0.884-596%-0.127-0.1270%--100%-0.858+576%-0.715+463%
Price Per Share9.760+86%1.4021.4020%-+100%3.129-55%2.608-46%
Price To Free Cash Flow Ratio-1.858-596%-0.267-0.2670%--100%6.121-104%5.101-105%
Price To Total Gains Ratio-1.395-596%-0.200-0.2000%---10.346+5061%-10.346+5061%
Quick Ratio--0.0490.0490%0.706-93%0.919-95%1.730-97%
Return On Assets---1.115-1.1150%-0.609-45%-0.629-44%-0.602-46%
Return On Equity----0%-41.8120%-8.9300%-7.7080%
Total Gains Per Share---6.995-6.9950%1.309-635%-2.176-69%-0.978-86%
Usd Book Value---54327909.600-54327909.6000%1651500.800-3390%90534.080-60108%6761038.667-904%
Usd Book Value Change Per Share---8.698-8.6980%1.484-686%-2.935-66%-1.407-84%
Usd Book Value Per Share---8.442-8.4420%0.257-3390%0.014-60108%1.051-904%
Usd Dividend Per Share----0%0.143-100%0.230-100%0.191-100%
Usd Eps---13.735-13.7350%-10.730-22%-10.335-25%-10.272-25%
Usd Free Cash Flow---42032436.400-42032436.4000%-46478306.400+11%-27943940.720-34%-23286617.267-45%
Usd Free Cash Flow Per Share---6.531-6.5310%-7.222+11%-5.428-17%-5.428-17%
Usd Free Cash Flow To Equity Per Share---3.827-3.8270%1.671-329%-1.211-68%-1.211-68%
Usd Market Cap78111477.054+86%11220521.60111220521.6010%-+100%25045292.653-55%20871077.211-46%
Usd Price Per Share12.138+86%1.7441.7440%-+100%3.892-55%3.243-46%
Usd Profit---88390113.600-88390113.6000%-69052133.600-22%-66512702.400-25%-66108117.867-25%
Usd Revenue--9293422.8009293422.8000%-1983542.000+121%31816013.680-71%31268663.867-70%
Usd Total Gains Per Share---8.698-8.6980%1.627-635%-2.705-69%-1.216-86%
 EOD+6 -2MRQTTM+0 -0YOY+11 -235Y+5 -3010Y+5 -30

3.2. Fundamental Score

Let's check the fundamental score of Santhera Pharmaceuticals Holding AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.884
Price to Book Ratio (EOD)Between0-1-1.438
Net Profit Margin (MRQ)Greater than0-9.511
Operating Margin (MRQ)Greater than0-6.138
Quick Ratio (MRQ)Greater than10.049
Current Ratio (MRQ)Greater than10.062
Debt to Asset Ratio (MRQ)Less than11.686
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.115
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Santhera Pharmaceuticals Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.695
Ma 20Greater thanMa 509.525
Ma 50Greater thanMa 1009.814
Ma 100Greater thanMa 2009.797
OpenGreater thanClose9.500
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets63,726
Total Liabilities107,412
Total Stockholder Equity-43,686
 As reported
Total Liabilities 107,412
Total Stockholder Equity+ -43,686
Total Assets = 63,726

Assets

Total Assets63,726
Total Current Assets3,065
Long-term Assets60,661
Total Current Assets
Cash And Cash Equivalents 1,353
Net Receivables 1,091
Inventory 108
Other Current Assets 513
Total Current Assets  (as reported)3,065
Total Current Assets  (calculated)3,065
+/-0
Long-term Assets
Property Plant Equipment 1,008
Intangible Assets 59,206
Other Assets 3
Long-term Assets  (as reported)60,661
Long-term Assets  (calculated)60,217
+/- 444

Liabilities & Shareholders' Equity

Total Current Liabilities49,414
Long-term Liabilities57,998
Total Stockholder Equity-43,686
Total Current Liabilities
Short-term Debt 24,975
Accounts payable 3,895
Other Current Liabilities 19,991
Total Current Liabilities  (as reported)49,414
Total Current Liabilities  (calculated)48,861
+/- 553
Long-term Liabilities
Other Liabilities 36,311
Long-term Liabilities  (as reported)57,998
Long-term Liabilities  (calculated)36,311
+/- 21,687
Total Stockholder Equity
Common Stock753
Retained Earnings -627,501
Accumulated Other Comprehensive Income 2,040
Other Stockholders Equity 581,022
Total Stockholder Equity (as reported)-43,686
Total Stockholder Equity (calculated)-43,686
+/-0
Other
Cash and Short Term Investments 1,353
Common Stock Shares Outstanding 6,093
Current Deferred Revenue553
Liabilities and Stockholders Equity 63,726
Net Debt 50,480
Net Tangible Assets -101,962
Short Long Term Debt Total 51,833



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
109,780
110,294
115,051
88,687
91,117
63,726
63,72691,11788,687115,051110,294109,780
   > Total Current Assets 
77,608
43,083
49,255
17,723
24,641
3,065
3,06524,64117,72349,25543,08377,608
       Cash And Cash Equivalents 
0
0
32,858
12,411
21,208
1,353
1,35321,20812,41132,85800
       Short-term Investments 
13,011
0
0
0
0
0
0000013,011
       Net Receivables 
5,402
7,861
8,901
4,487
1,936
1,091
1,0911,9364,4878,9017,8615,402
       Inventory 
10,147
9,282
6,859
481
428
108
1084284816,8599,28210,147
       Other Current Assets 
3,000
3,000
637
344
1,069
513
5131,0693446373,0003,000
   > Long-term Assets 
0
0
65,796
70,964
66,476
60,661
60,66166,47670,96465,79600
       Property Plant Equipment 
2,157
2,269
5,604
1,902
1,324
1,008
1,0081,3241,9025,6042,2692,157
       Intangible Assets 
23,560
61,467
58,479
67,673
64,596
59,206
59,20664,59667,67358,47961,46723,560
> Total Liabilities 
77,524
82,465
93,804
95,041
89,789
107,412
107,41289,78995,04193,80482,46577,524
   > Total Current Liabilities 
13,246
19,709
23,964
29,069
32,782
49,414
49,41432,78229,06923,96419,70913,246
       Short-term Debt 
0
0
1,013
11,364
17,627
24,975
24,97517,62711,3641,01300
       Accounts payable 
3,585
7,194
6,832
3,803
2,412
3,895
3,8952,4123,8036,8327,1943,585
       Other Current Liabilities 
1,581
1,474
14,522
12,776
12,477
19,991
19,99112,47712,77614,5221,4741,581
   > Long-term Liabilities 
0
0
69,840
65,972
57,007
57,998
57,99857,00765,97269,84000
> Total Stockholder Equity
32,256
27,829
21,247
-6,354
1,328
-43,686
-43,6861,328-6,35421,24727,82932,256
   Retained Earnings -627,501-556,425-500,899-433,240-414,267-360,081
   Accumulated Other Comprehensive Income 
0
0
-4,017
-3,310
-1,348
2,040
2,040-1,348-3,310-4,01700
   Capital Surplus 
392,002
435,795
448,084
480,005
0
0
00480,005448,084435,795392,002
   Treasury Stock00-1,580-745-904-335



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue7,473
Cost of Revenue-4,200
Gross Profit3,2733,273
 
Operating Income (+$)
Gross Profit3,273
Operating Expense-49,140
Operating Income-45,867-45,867
 
Operating Expense (+$)
Research Development30,536
Selling General Administrative14,565
Selling And Marketing Expenses10,857
Operating Expense49,14055,958
 
Net Interest Income (+$)
Interest Income-
Interest Expense-20,189
Other Finance Cost-20,189
Net Interest Income-
 
Pretax Income (+$)
Operating Income-45,867
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-70,616-21,118
EBIT - interestExpense = -66,056
-70,616
-50,887
Interest Expense20,189
Earnings Before Interest and Taxes (EBIT)-45,867-50,427
Earnings Before Interest and Taxes (EBITDA)-42,219
 
After tax Income (+$)
Income Before Tax-70,616
Tax Provision--
Net Income From Continuing Ops--70,616
Net Income-71,076
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses53,340
Total Other Income/Expenses Net-24,7490
 

Technical Analysis of Santhera
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Santhera. The general trend of Santhera is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Santhera's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Santhera Pharmaceuticals Holding AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 9.78 < 9.8299 < 11.34.

The bearish price targets are: 16.46 > 15.24 > 14.02.

Tweet this
Santhera Pharmaceuticals Holding AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Santhera Pharmaceuticals Holding AG. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Santhera Pharmaceuticals Holding AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Santhera Pharmaceuticals Holding AG. The current macd is -0.11414239.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Santhera price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Santhera. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Santhera price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Santhera Pharmaceuticals Holding AG Daily Moving Average Convergence/Divergence (MACD) ChartSanthera Pharmaceuticals Holding AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Santhera Pharmaceuticals Holding AG. The current adx is 12.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Santhera shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Santhera Pharmaceuticals Holding AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Santhera Pharmaceuticals Holding AG. The current sar is 8.9999.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Santhera Pharmaceuticals Holding AG Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Santhera Pharmaceuticals Holding AG. The current rsi is 52.69. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Santhera Pharmaceuticals Holding AG Daily Relative Strength Index (RSI) ChartSanthera Pharmaceuticals Holding AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Santhera Pharmaceuticals Holding AG. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Santhera price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Santhera Pharmaceuticals Holding AG Daily Stochastic Oscillator ChartSanthera Pharmaceuticals Holding AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Santhera Pharmaceuticals Holding AG. The current cci is 67.75.

Santhera Pharmaceuticals Holding AG Daily Commodity Channel Index (CCI) ChartSanthera Pharmaceuticals Holding AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Santhera Pharmaceuticals Holding AG. The current cmo is 13.92.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Santhera Pharmaceuticals Holding AG Daily Chande Momentum Oscillator (CMO) ChartSanthera Pharmaceuticals Holding AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Santhera Pharmaceuticals Holding AG. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Santhera Pharmaceuticals Holding AG Daily Williams %R ChartSanthera Pharmaceuticals Holding AG Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Santhera Pharmaceuticals Holding AG.

Santhera Pharmaceuticals Holding AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Santhera Pharmaceuticals Holding AG. The current atr is 0.20504931.

Santhera Pharmaceuticals Holding AG Daily Average True Range (ATR) ChartSanthera Pharmaceuticals Holding AG Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Santhera Pharmaceuticals Holding AG. The current obv is -89,798.

Santhera Pharmaceuticals Holding AG Daily On-Balance Volume (OBV) ChartSanthera Pharmaceuticals Holding AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Santhera Pharmaceuticals Holding AG. The current mfi is 38.07.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Santhera Pharmaceuticals Holding AG Daily Money Flow Index (MFI) ChartSanthera Pharmaceuticals Holding AG Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Santhera Pharmaceuticals Holding AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Santhera Pharmaceuticals Holding AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Santhera Pharmaceuticals Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.695
Ma 20Greater thanMa 509.525
Ma 50Greater thanMa 1009.814
Ma 100Greater thanMa 2009.797
OpenGreater thanClose9.500
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Santhera with someone you think should read this too:
  • Are you bullish or bearish on Santhera? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Santhera? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Santhera Pharmaceuticals Holding AG

I send you an email if I find something interesting about Santhera Pharmaceuticals Holding AG.


Comments

How you think about this?

Leave a comment

Stay informed about Santhera Pharmaceuticals Holding AG.

Receive notifications about Santhera Pharmaceuticals Holding AG in your mailbox!